Sipuleucel-T Not Yet Recruiting Phase 3 Trials for Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT06134232Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T